Biliary events and an increased risk of new onset irritable bowel syndrome: A population-based cohort study

Alimentary Pharmacology and Therapeutics

Volumn 28, Issue 3, 2008, Pages 334-343

  Mcnally, M A ^a,b   Locke, G R ^a,b   Zinsmeister, A R ^a,b   CDSchieck, ^a,b   JPeterson, ^a,b   Talley, N J ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BILIARY TRACT DISEASE; BODY MASS; CHOLECYSTECTOMY; COHORT ANALYSIS; CONSTIPATION; DISEASE PREDISPOSITION; ETHNIC DIFFERENCE; FEMALE; FOLLOW UP; GALLSTONE; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SEX RATIO; STATISTICAL ANALYSIS;

BILIARY TRACT DISEASES; CHOLECYSTECTOMY; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; RISK ASSESSMENT;

EID: 64649084671     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2008.03715.x     Document Type: Article

References (46)

1. Thompson W, Longstreth G, Drossman D, Heaton K, Irviine E, Muller-Lissner S. Functional bowel disorders and functional abdominal pain. Gut 1999; 45(Suppl. 2): 43-7.
2. amilleri MC, Williams DE. Economic burden of irritable bowel syndrome: proposed strategies to control expenditures. Pharmacoeconomics 2000; 4: 331-8.
3. Patel RP, Petitta A, Fogel R, Peterson E, Zarowitz BJ. The economic impact of irritable bowel syndrome in a managed care setting. J Clin Gastroenterol 2002; 35: 14-20.
4. Levy RL, Whitehead WE, Von Korff MR, Feld AD. Intergenerational transmission of gastrointestinal illness behavior. Am J Gastroenterol 2000; 95: 451-6.
5. Levy RL, Von Korff M, Whitehead WE, et al. Costs of care for irritable bowel syndrome patients in a health maintenance organization. Am J Gastroenterol 2001; 96: 3122-9.
6. Longstreth GF, Wilson A, Knight K, et al. Irritable bowel syndrome, health care use, and costs: a U.S. managed care perspective. Am J Gastroenterol 2003; 98: 600-7.
7. Romero Y, Thistle JL, Longstreth GF, et al. A questionnaire for the assessment of biliary symptoms. Am J Gastroenterol 2003; 98: 1042-51.
8. Heaton KW, Braddon FE, Mountford RA, Hughes AO, Emmett PM. Symptomatic and silent gall stones in the community. Gut 1991; 32: 316-20.
9. Longstreth GF, Yao JF. Irritable bowel syndrome and surgery: a multivariate analysis. Gastroenterology 2004; 126: 1665-73.
10. Ros E, Zambon D. Postcholecystectomy symptoms. A prospective study of gallstone patients before and two years after surgery. Gut 1987; 28: 1500-4.
11. Kennedy TM, Jones RH. Epidemiology of cholecystectomy and irritable bowel syndrome in a UK population. Br J Surg 2000; 87: 1658-63.
12. Melton LJ III. History of the Rochester Epidemiology Project. Mayo Clin Proc 1996; 71 : 266-74.
13. Kurland LT, Molgaard CA. The patient record in epidemiology. Sci Am 1981; 245: 54-63.
14. McGovern TW, Talley NJ, Kephart GM, Carpenter HA, Gleich GJ. Eosinophil infiltration and degranulation in Helicobacter pylori-associated chronic gastritis. Dig Dis Sci 1991; 36: 435-40.
15. O'Keefe EA, Talley NJ, Tangalos EG, Zinsmeister AR. A bowel symptom questionnaire for the elderly. J Gerontol 1992; 47: M116-21.
16. Drossman DA, Talley NJ, Leserman J, Olden KW, Barreiro MA. Sexual and physical abuse and gastrointestinal illness. Review and recommendations. Ann Intern Med 1995; 123: 782-94.
17. Halder SLS, Locke GRI, Fett SL, Zins- meister AR, Melton LJI. Impact of functional gastrointestinal disorders on health-related quality of life: a population-based case-control study. Aliment Pharmacol Ther 2004; 19: 233-42.
18. Talley NJ, Zinsmeister AR, Van Dyke C, Melton LJ 3rd. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991; 101: 927-34.
19. Talley NJ, Zinsmeister AR, Melton LJ III. Irritable bowel syndrome in a community: symptom subgroups, risk factors and health care utilization. Am J Epidemiol 1995; 142: 76-83.
20. Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ 3rd. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 1992; 102: 1259-68.
21. Talley NJ, Phillips SF, Melton J 3rd, Wiltgen C, Zinsmeister AR. A patient questionnaire to identify bowel disease. Ann Intern Med 1989; 111: 671-4.
22. Castillo EJ, Camilleri M, Locke GR, etal. A community-based, controlled study of the epidemiology and pathophysiology of dyspepsia. Clin Gastroenterol Hepatol 2004; 2: 985-96.
23. Talley N, Phillips S, Wiltgen C, Zinsmei- ster A, Melton LJ. Assessment of functional gastrointestinal disease: the Bowel Disease Questionnaire. Mayo Clin Proc 1990; 65: 1456-79.
24. Manning AP, Thompson WG, Heaton KW, Morris AF. Towards positive diagnosis of the irritable bowel. Br Med J 1978; 2: 653-4.
25. Burns DG. The risk of abdominal surgery in irritable bowel syndrome. S Afr Med J 1986; 70: 91.
26. Walker EA, Gelfand AN, Gelfand AN, Green C, Katon WJ. Chronic pelvic pain and gynecological symptoms in women with irritable bowel syndrome. J Psy- chosom Obstet Gynaecol 1996; 17: 3946.
27. Ryle JA. An address on chronic spasmodic affections of the colon and diseases which they simulate. Lancet 1928; 2: 1115-9.
28. Drossman DA, Thompson WG. The irritable bowel syndrome: review and a graduated multicomponent treatment approach. Ann Intern Med 1992; 116(12 Pt 1): 1009-16.
29. Legorreta AP, Silber JH, Costantino GN, Kobylinski RW, Zatz SL. Increased cho- lecystectomy rate after the introduction of laparoscopic cholecystectomy. JAMA 1993; 270: 1429-32.
30. Cole JA, Yeaw JM, Cutone JA, et al. The incidence of abdominal and pelvic surgery among patients with irritable bowel syndrome. Dig Dis Sci 2005; 50: 2268-75.
31. Mallon P, White J, McMenamin M, Das N, Hughes D, Gilliland R. Increased cho- lecystectomy rate in the laparoscopic era: a study of the potential causative factors. Surg Endosc 2006; 20: 883-6.
32. Crean GP, Holden RJ, Knill-Jones RP, et al. A database on dyspepsia. Gut 1994; 35: 191-202.
33. Kellow JE, Miller LJ, Phillips SF, Zins-meister AR, Charboneau JW. Altered sensitivity of the gallbladder to chole- cystokinin octapeptide in irritable bowel syndrome. Am J Physiol. 1987; 253(5 Pt 1): G650-5.
34. Kamath PS, Gaisano HY, Phillips SF, et al. Abnormal gallbladder motility in irritable bowel syndrome: evidence for target-organ defect. Am J Physiol. 1991; 260(6 Pt 1): G815-9.
35. Sood GK, Baijal SS, Lahoti D, Broor SL. Abnormal gallbladder function in patients with irritable bowel syndrome. Am J Gastroenterol 1993; 88: 1387-90.
36. Misra SP, Dwivedi M, Mital M, Misra V. Gallbladder dynamics in patients with irritable bowel syndrome and essential dyspepsia. J Clin Gastroenterol 1991; 13: 65-8.
37. Hennig R, Zanli J, Osman T, etal.Asso- ciation between gallstone-evoked pain, inflammation and proliferation of nerves in the gallbladder: a possible explanation for clinical differences. Scand J Gastroenterol 2007; 42: 878-84.
38. Ford GA, Preece JD, Davies IH, Wilkinson SP. Use of the SeHCAT test in the investigation of diarrhoea. Postgrad Med J 1992; 68: 272-6.
39. Schiller LR, Hogan RB, Morawski SG, et al. Studies of the prevalence and significance of radiolabeled bile acid mal- absorption in a group of patients with idiopathic chronic diarrhea. Gastroenter- ology 1987; 92: 151-60.
40. Suhr O, Danielsson A, Nyhlin H, Trueds- son H. Bile acid malabsorption demonstrated by SeHCAT in chronic diarrhoea, with special reference to the impact of cholecystectomy. Scand J Gastroenterol 1988; 23 : 1187-94.
41. Sciarretta G, Furno A, Mazzoni M, Mal- aguti P. Post-cholecystectomy diarrhea: evidence of bile acid malabsorption assessed by SeHCAT test. Am J Gastro- enterol 1992; 87: 1852-4.
42. Vander Velpen GC, Shimi SM, Cuschieri A. Outcome after cholecystectomy for symptomatic gall stone disease and effect of surgical access: laparoscopic v open approach. Gut 1993; 34: 1448-51.
43. Saito YA, Schoenfeld P, Locke GR III. The epidemiology of irritable bowel syndrome in North America: a systematic review. Am J Gastroenterol 2002; 97: 1910-5.
44. Hungin AP, Chang L, Locke GR, Dennis EH, Barghout V. Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact. Aliment Pharmacol Ther 2005; 21: 1365-75.
45. Andrews EB, Eaton SC, Hollis KA, et al. Prevalence and demographics of irritable bowel syndrome: results from a large web-based survey. Aliment Pharmacol Ther 2005; 22: 935-42.
46. Mendall MA, Kumar D. Antibiotic use, childhood affluence and irritable bowel syndrome (IBS). Eur J Gastroenterol Hepatol 1998; 10: 59-62.